215 related articles for article (PubMed ID: 30569129)
1. MicroRNA‑206 exerts anti‑oncogenic functions in esophageal squamous cell carcinoma by suppressing the c‑Met/AKT/mTOR pathway.
Zhang J; Fa X; Zhang Q
Mol Med Rep; 2019 Mar; 19(3):1491-1500. PubMed ID: 30569129
[TBL] [Abstract][Full Text] [Related]
2. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
3. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
4. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
6. hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma.
Shi Y; Guo Z; Fang N; Jiang W; Fan Y; He Y; Ma Z; Chen Y
Biomed Pharmacother; 2019 Sep; 117():109151. PubMed ID: 31229921
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.
Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H
Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
9. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
[TBL] [Abstract][Full Text] [Related]
10. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.
Cui D; Zhu Y; Yan D; Lee NPY; Han L; Law S; Tsao GSW; Cheung ALM
Carcinogenesis; 2021 Jul; 42(7):995-1007. PubMed ID: 34089582
[TBL] [Abstract][Full Text] [Related]
12. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
14. MiR-34a reverses radiation resistance on ECA-109 cells by inhibiting PI3K/AKT/mTOR signal pathway through downregulating the expression of SIRT1.
Ye Z; Xie T; Yan F; Wang L; Fang J; Wang Z; Hu F; Wang F; Fu Z
Int J Radiat Biol; 2021; 97(4):452-463. PubMed ID: 33507132
[TBL] [Abstract][Full Text] [Related]
15. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
16. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
17. AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway.
Zhang ZF; Huang TJ; Zhang XK; Xie YJ; Lin ST; Luo FF; Meng DF; Hu H; Wang J; Peng LX; Qian CN; Cheng C; Huang BJ
J Cell Mol Med; 2020 Sep; 24(17):9999-10012. PubMed ID: 32678482
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.
Sun J; Chen Z; Tan X; Zhou F; Tan F; Gao Y; Sun N; Xu X; Shao K; He J
Med Oncol; 2013 Mar; 30(1):411. PubMed ID: 23292834
[TBL] [Abstract][Full Text] [Related]
19. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
20. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
